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Abstract
Background Small bowel obstruction (SBO) is characterized by a high rate of recurrence. In the present study, we
aimed to compare the outcomes of patients managed either by conservative treatment or surgical operation for an
episode of SBO.
Methods The outcomes of all patients hospitalized at a single center for acute SBO between 2004 and 2007 were
assessed. The occurrence of recurrent hospitalization, surgery, SBO symptoms at home, and mortality was
determined.
Results Among 221 patients admitted with SBO, 136 underwent a surgical procedure (surgical group) and 85 were
managed conservatively (conservative group). Baseline characteristics were similar between treatment groups. The
median follow-up time (interquartile range) was 4.7 (3.7–5.8) years. Nineteen patients (14.0 %) of the surgical group
were hospitalized for recurrent SBO versus 25 (29.4 %) of the conservative group [hazard ratio (HR), 0.5; 95 % CI,
0.3–0.9]. The need for a surgical management of a new SBO episode was similar between the two groups, ten patients
(7.4 %) in the surgical group and six patients (7.1 %) in the conservative group (HR, 1.1; 95 % CI, 0.4–3.1). Five-
year mortality from the date of hospital discharge was not significantly different between the two groups (age- and
sex-adjusted HR, 1.1; 95 % CI, 0.6–2.1). A follow-up evaluation was obtained for 130 patients. Among them, 24
patients (34.8 %) of the surgical group and 35 patients (57.4 %) of the conservative group had recurrent SBO
symptoms (odds ratio, 0.4; 95 % CI, 0.2–0.8).
Conclusions The recurrence of SBO symptoms and new hospitalizations were significantly lower after surgical
management of SBO compared with conservative treatment.
Introduction
Acute small bowel obstruction (SBO) accounts for about
20 % of all surgical emergencies in Western societies [1].
Small bowel obstruction is caused mainly by postoperative
adhesions (more than 75 % of all cases) [2–6]. The oper-
ative procedures usually associated with SBO are colec-
tomy, hysterectomy, and appendectomy [7]. Other causes
of SBO are Crohn’s disease (7 %), neoplasm (5–10 %),
hernia (2 %), or radiation-induced enteritis (1 %) [2–5]. In
a series of 29,790 patients with a single previous abdominal
or pelvic surgery, Ellis et al. reported that within the
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following 10 years 34.6 % of them were readmitted with a
mean of 2.1 times for a disease related to adhesions [8].
About 10 % of patients have ‘‘spontaneous’’ SBO with no
previous abdominal surgery [5]. The management of SBO
is based on clinical evaluation, biological tests, and com-
puted tomography (CT) imaging. Conservative treatment
with bowel rest, nasogastric tube decompression, and fluid
resuscitation is successful in a variable proportion of
patients [9]. In conservative management, regular reas-
sessment is mandatory for early recognition of signs of
bowel ischemia that would require a surgical operation.
Patients with clinical degradation or with a CT scan
evoking strangulated SBO need urgent surgery [10, 11]. In
a significant proportion of patients both therapeutic options
are valid; the choice of the treatment depends mainly on
the clinician’s assessment, and therefore it represents a
common clinical challenge. On the one hand, successful
conservative treatment may leave adhesions that could
cause recurrence; on the other hand, surgery may be the
source of new adhesions like any other abdominal surgery
[12, 13]. Landercasper et al. reported a 42 % risk of SBO
recurrence by 10 years, which is lessened in surgically
treated patients compared to their conservatively treated
counterparts [14]. Another retrospective study analyzed the
pattern of recurrence after one or more episodes of SBO
[15]; the rate of SBO recurrence was shown to increase
proportionally to the number of previous SBO episodes.
In the present study, we report a long-term follow-up of
patients treated with surgical versus conservative approach
for SBO. The aim was to compare the rate of SBO recur-
rence, resulting in new hospitalization with or without
surgery, as well as the occurrence of SBO symptoms, such
as recurrent abdominal pain, at home.
Patients and methods
Study design and population
This is a retrospective single-center study of patients hos-
pitalized at University Hospitals of Geneva with acute
adhesive SBO between January 2004 and December 2007.
The study was approved by the local research ethics
committee (protocol NAC 10–015). During the study per-
iod, all consecutive patients admitted in our center with an
episode of SBO were included in the study. An SBO epi-
sode was defined using the code K56.5 from the Interna-
tional Classification of Diseases, 10th Revision (ICD-10).
The first hospitalization for SBO occurring during the study
period was defined as the index date, and hereafter we refer
to the ‘‘index SBO episode’’ (and respectively, ‘‘index
hospitalization’’ or ‘‘index surgery’’). Management inclu-
ded either a standard conservative treatment with
intravenous fluid infusion, analgesics and nasogastric tube;
or surgical treatment including exploratory laparotomy
with adhesiolysis, with or without small bowel resection.
Exclusion criteria were large bowel obstruction, incarcer-
ated abdominal wall hernia, early postoperative SBO
(within 1 month), inflammatory bowel disease, radiation-
induced intestinal fibrosis, and peritoneal carcinomatosis.
Study variables
The computerized records of the included patients were
reviewed for complete information regarding their past
surgical history and clinical data about the index SBO
episode. Small bowel obstruction severity score was cal-
culated as described in Schwenter et al. [16]. Rehospitali-
zation(s) caused by recurrent SBO and the nature of
treatment (surgical vs. conservative) were retrieved from
institutional computerized records for every patient. Non-
readmitted patients were contacted by phone in order to
assess any recurrence of SBO symptoms. Vital status was
obtained from the state population office of statistics.
Patients were followed up until May 2011.
Statistical analysis
Differences between groups were analyzed with the t test
for continuous variables and the Chi square test for binary
and categorical variables. Survival analyses were per-
formed with the Kaplan–Meier method and the log rank
test. Uni-/multivariate Cox proportional-hazards regression
was used to compute hazard ratios (HR). Ninety-five per-
cent confidence intervals (95 % CI) were reported, and an
exact two-sided p value \0.05 was considered statistically
significant.
Results
Patient characteristics
During the study period, 221 patients were hospitalized for
an index SBO episode. The mean age of patients was 67
(±18) years, and there were 131 women (59.3 %). Patients
were categorized into two groups according to their index
treatment. One hundred thirty-six patients (61.5 %)
underwent operation (surgical group) and 85 patients
(38.5 %) were managed with medical treatment (conser-
vative group). Age and sex were equally distributed in the
two groups (Table 1). One hundred twenty-one patients
(89.0 %) from the surgical group and 80 patients (94.1 %)
from the conservative group had had one or more previous
abdominal operations (p = 0.234). The numbers and types
of previous abdominal operations were similar in the two
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groups. Eighteen patients (13.2 %) from the surgical group
and 19 patients (22.4 %) from the conservative group had
had one or more previous SBO episode (p = 0.096); the
type of the management of the previous SBO epi-
sode(s) (surgical vs. conservative) was similar for the two
groups (a patient was considered as surgically treated when
at least one operation was reported in the past surgical
history). At the time of index hospitalization, clinical
severity score was calculated as follows (one point was
given for each present item): pain duration C4 days,
abdominal guarding, leukocyte C10 9 109/l, C-reactive
protein C75 mg/l, free fluid C500 ml on CT scan, reduced
contrast enhancement on CT scan; (min–max: 0–6) [16].
As expected, the clinical severity score was higher in the
surgical group than in the conservative group (p \ 0.001).
Forty-nine patients (36.0 %) had a score C3 in the surgical
group, compared to seven patients (8.2 %) in the conser-
vative group. Decision making for surgical management is
given in Table 1. Among the ten patients who underwent
laparotomy with a severity score of 0, seven had a transi-
tion zone on CT scan, two underwent operation because of
a clinical degradation, and one had small bowel dilatation
[4.5 cm on CT scan. In the surgical group, 17 patients
(12.5 %) had a delayed surgery (i.e., beyond 24 h after
hospital admission) and 44 (32.4 %) required bowel
resection. Patients in the surgical group had a significantly
longer hospital stay than patients in the conservative
Table 1 Patient characteristics
Variable Surgical
management
(n = 136)
Conservative
management
(n = 85)
p valuea
Age, years (mean ± SD) 68.4 ± 18.4 64.7 ± 16.5 0.133
Sex, male (%) 52 (38.2) 38 (44.7) 0.399
Previous abdominal
operation (%)
121 (89.0) 80 (94.1) 0.234
Patients with previous surgery (%)
0 abdominal operation 15 (11.0) 5 (5.9) 0.120
1 abdominal operation 56 (41.2) 28 (32.9)
2 or more abdominal
operations
65 (47.8) 52 (61.2)
Previous
appendectomy (%)
63 (46.3) 41 (48.2) 0.784
Previous
cholecystectomy (%)
21 (15.4) 14 (16.5) 0.852
Previous colorectal
surgery (%)
25 (18.4) 24 (28.2) 0.097
Previous gynecologic
surgery (%)
26 (19.1) 21 (24.7) 0.398
Previous urologic
surgery (%)
8 (5.9) 7 (8.2) 0.585
Previous hernia repair (%) 18 (13.2) 7 (8.2) 0.283
Previous gastric
surgery (%)
11 (8.1) 4 (4.7) 0.417
Previous small bowel
surgery (%)
5 (3.7) 6 (7.1) 0.342
Previous vascular
surgery (%)
2 (1.5) 3 (3.5) 0.375
Previous operation for
cancer (%)
22 (16.2) 12 (14.1) 0.707
Previous SBO
episode(s) managed
surgically (%)
4 (2.9) 4 (4.7) 0.488
Previous SBO
episode(s) managed
conservatively (%)
14 (10.3) 15 (17.6) 0.151
Clinical severity score (%)b
0 10 (7.4) 15 (17.6) \0.001
1 31 (22.8) 30 (35.3)
2 46 (33.8) 33 (38.8)
3 38 (27.9) 6 (7.1)
4 10 (7.4) 1 (1.2)
5 1 (0.7) 0 (0.0)
6 0 (0.0) 0 (0.0)
Decision making for surgical management (%)
CT transition zone 83 (61.0) NA NA
Clinical degradationc 23 (16.9)
CT: volvulus 18 (13.2)
CT: reduced contrast
enhancement
8 (5.9)
Otherd 4 (2.9)
Delay before surgery C24 h
(%)
17 (12.5) NA NA
Table 1 continued
Variable Surgical
management
(n = 136)
Conservative
management
(n = 85)
p valuea
Small bowel resection (%) 44 (32.4) NA NA
Length of index hospital
stay, days (mean ± SD)
12.0 ± 8.5 6.6 ± 3.6 \0.001
Death during the index
hospital stay (%)e
9 (6.6) 0 (0.0) 0.014
Recorded during the index hospitalization for a SBO episode
SD standard deviation, NA not applicable, SBO small bowel
obstruction
a Student’s t test for continuous variables, v2 test for binary or cat-
egorical variable (global p value)
b Calculated as described by Schwenter et al. 2010. One point was
given for each present feature: pain duration C4 days, abdominal
guarding, leukocyte count C10 9 109/l, C-reactive protein C75 mg/l,
free fluid C500 ml on CT scan, reduced contrast enhancement on CT
scan. The score ranged from 0 to 6
c Development of peritonism, no flatus after 24 h of observation, or
hemodynamic instability
d Includes diffuse small bowel feces sign (n = 1), small bowel
dilatation [4.5 cm (n = 1), SB wall major inflammation (n = 2)
e Death occurring B30 days after SBO surgery or conservative
management initiation
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group—12.0 (±8.5) versus 6.6 (±3.6) days, respectively
(p \ 0.001). Nine patients (6.6 %) died during the post-
operative course of the index SBO surgery; patient char-
acteristics and cause of death are available in Supplemental
Table S1 that can be found online at electronic supple-
mentary material section. In these nine patients, the mean
age was 77 (±17) years, and the most common cause of
death was postoperative pulmonary distress. No death was
reported for the conservative group during the 30 days
following the index hospital stay.
Comparison of readmission and operation hazard ratios
associated with management (surgical vs. conservative)
The median follow-up time (interquartile range) for the
whole study population was 4.7 (3.7–5.8) years. Nineteen
patients (14.0 %) from the surgical group were rehospi-
talized for a new SBO episode, as were 25 patients
(29.4 %) from the conservative group (Table 2). Among
the 19 patients who had postoperative SBO, 2 had SBO
recurrence within the 30-day postoperative period (both
underwent reoperation), and 8 others had SBO recurrence
within 1 year following the index operation (5 underwent
reoperation). The mean interval between the first hospi-
talization and rehospitalization was 1.1 (±1.1) years in the
surgery group and 1.7 (±1.4) years in the conservative
group (p = 0.121). Four patients (2.9 %) in the surgical
group were readmitted twice or more, whereas seven
patients (8.2 %) in the conservative group required more
than one readmission. Among those initially assigned to
the surgical group, ten patients (7.4 %) needed a surgical
treatment for recurrent SBO compared with six patients
(7.1 %) in the conservative group. The need for a bowel
resection during surgery for recurrent SBO was non-sig-
nificantly lower in the surgery group compared to the
conservative group. Seven patients from the surgical group
required reoperation within 1 year, two of them during the
30-day postoperative period. The first of those two patients
was reoperated for persistence of clinical signs of SBO, and
during that operation the surgeon found an extensive area
of necrosis of the small bowel that needed resection. The
second patient had a good initial evolution, but 2 weeks
postoperatively a clinical degradation developed, with
abdominal pain, elevated markers of inflammation, and a
CT scan showing a segmental ischemic small bowel and
free fluid; operation revealed a segmental small bowel
necrosis with perforation, and this segment was resected.
The remaining five patients underwent reoperation 50, 177,
184, 230, and 351 days after the index operation. Extensive
adhesions were found in four of them; in one patient who
had a surgical history of gastric bypass, mesenteric win-
dows were closed. None of the patients required a small
bowel resection.
Two patients (1.5 %) in the surgical group and one
(1.2 %) in the conservative group required operation to
treat further SBO recurrence. Overall, 44 patients (32.4 %)
died in the surgical group and 15 (17.6 %) in the conser-
vative group. The age- and sex-adjusted HR for surgery
was 1.5; 95 % CI, 0.8–2.7; p = 0.196. When considering
only death occurring more than 30 days after SBO surgery
or conservative management initiation (i.e., excluding
postoperative death), the age- and sex-adjusted HR (95 %
CI) was 1.1 (0.6–2.1); p = 0.690. Kaplan–Meier estimates
of the hospitalization-free survival, operation-free survival,
overall survival, and survival from the date of hospital
discharge ([30 days after admission) are shown in Fig. 1.
Table 2 Hospitalization and operation for SBO recurrence, and overall mortality associated with index management (surgical vs. conservative)
Variable Surgical
management
(n = 136)
Conservative
management
(n = 85)
Unadjusted HR for
surgery (95 % CI)
p value Adjusted HR for
surgery (95 % CI)a
p value
Hospitalization for
recurrent SBO (%)
19 (14.0) 25 (29.4) 0.5 (0.3–0.9) 0.016 0.5 (0.3–0.9) 0.014
[1 hospitalization for
recurrent SBO (%)
4 (2.9) 7 (8.2) 0.3 (0.1–1.1) 0.063 0.3 (0.1–1.1) 0.066
Patients operated for SBO
recurrence (%)
10 (7.4) 6 (7.1) 1.1 (0.4–3.1) 0.824 1.1 (0.4–3.0) 0.852
Small bowel resection
(%)
3 (2.2) 3 (3.5) 0.7 (0.1–3.3) 0.610 0.6 (0.1–2.9) 0.489
[1 operation for recurrent
SBO (%)
2 (1.5) 1 (1.2) 1.2 (0.1–13.5) 0.870 1.2 (0.1–13.5) 0.869
Death until end of follow-
up (%)
44 (32.4) 15 (17.6) 2.0 (1.1–3.6) 0.023 1.5 (0.8–2.7) 0.196
Hazard ratios (HR) and p values were calculated with univariate and multivariate Cox proportional-hazards regression analysis
a Age- and sex-adjusted
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Comparison of small bowel obstruction symptoms
between surgical and conservative groups
A follow-up evaluation was obtained for 130 patients
[80.2 % of the patients still alive (130/162)]. The
remaining patients had invalid or missing contact infor-
mation (n = 32). Comparing the surgical group versus the
conservative group, we found that 24 patients (34.8 %) in
the surgical group had SBO symptom recurrence, versus
35 patients (57.4 %) in the conservative group (Table 3).
Almost all symptomatic patients reported that they suf-
fered from abdominal pain. Nausea and vomiting were
reported by 25.4 % of the symptomatic patients (15/59).
The delay to SBO symptom recurrence following the
index hospitalization did not differ significantly between
the surgical group and the conservative group [mean
(± SD) 1.1 (0.9.)] year in both groups; p = 0.925). In
symptomatic patients, the median frequency of abdominal
pain episodes was one episode per week (range: 0–14);
nausea and vomiting were reported to occur twice a week
(range: 1–14).
Comparison between patients operated after 24 h
of admission and those operated within 24 h
for an index SBO episode
Patients operated beyond 24 h after admission for an SBO
episode had a non-significantly lower rehospitalization rate
and similar overall mortality, compared with those who
were operated within 24 h of admission (Supplemental
Table S2, online electronic supplementary material).
Reoperation for small bowel obstruction recurrence was
not observed in patients operated 24 h beyond their
admission. Ten patients in the \24 h group underwent
reoperation. Symptoms of SBO occurrence (considering
patients who responded to follow-up evaluation) was
similar between the two groups [25.0 % (2/8) vs. 36.1 %
(22/61), OR, 0.6; 95 % CI, 0.1–3.2; p = 0.540].
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Fig. 1 Kaplan–Meier estimates of a the hospitalization-free survival, b operation-free survival, c overall survival, and d survival from hospital
discharge (i.e., excluding patients who died within 30 days after admission). p values were calculated with the log rank test. Age- and sex-
adjusted p values were calculated with multivariate Cox proportional-hazards regression analysis
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Comparison between patients with and without small
bowel resection during the index SBO episode
management
Patients who underwent a small bowel resection during the
index SBO episode had a similar rehospitalization rate and
a nonsignificantly higher operation rate for small bowel
obstruction recurrence, as well as similar overall mortality,
compared to those who had no resection (Supplemental
Table S3, online electronic supplementary material).
Symptoms of SBO occurrence (considering patients who
responded to follow-up evaluation) were similar between
the two groups [35.0 % (7/20) vs. 34.7 % (17/49), OR, 1.0;
95 % CI, 0.3–3.0; p = 0.981].
Discussion
In the present study we compared the outcomes of patients
treated either by surgical or conservative management for
an SBO episode. The main findings are that patients treated
by surgery are 50 % less likely to require rehospitalization
and 60 % less likely to suffer from ‘‘everyday’’ SBO
symptoms at home compared with those managed by a
conservative approach. Furthermore, surgery for SBO does
not significantly modify the rate of a subsequent SBO
operation.
Our results concerning SBO recurrence are in accor-
dance with those of Landercasper et al., who reported a
statistically significant difference in rehospitalization rates
between patients treated surgically (21 %) or conserva-
tively (38 %) (p = 0.001) [14]. They observed operation
rates for a new SBO episode of 10 and 17 %, respectively
(p = 0.08). Of note, patients with SBO episodes caused
by malignancy and inflammatory bowel disease were also
included by Landerscaper et al.; this may explain the
higher recurrence rates compared to our study. Fevang
et al. reported that their patients who had surgery were
45 % less likely to suffer from recurrent SBO than
patients managed conservatively (relative risk, 0.55; 95 %
CI, 0.35–0.86) [15]. They also reported that the risk of
being operated for a new SBO episode is the same
regardless of the initial treatment (relative risk, 0.79;
95 % CI, 0.39–1.59). Our results regarding morbidity of
SBO patients according to the type of treatment received
are consistent with previous studies [14, 17–20]. Con-
cerning the postoperative mortality, a 6.6 % 30-day
mortality rate was observed in our study, which is in
accordance with other reports [4, 18, 19]. Overall, more
patients died in the surgical group than in the conservative
group. However, the modality of treatment seemed not to
be involved in this difference. Indeed, the patients in the
surgical group were slightly older that patients treated
conservatively, and once adjusted for age and sex, overall
mortality was not different between the two groups.
Moreover, only the sickest of patients died during the
postoperative period.
The assessment of SBO symptoms occurrence obtained
by phone calls showed that conservatively treated patients
had a significantly higher rate of SBO symptoms in their
everyday life than surgically treated ones. This result is of
importance for the decision-making process regarding the
optimal treatment, as it indicates that patients who
underwent surgical management have decreased risks of
recurrence. Fevang et al. reported that patients treated for
SBO were more prone to experiencing abdominal pain
than the normal subjects (especially women and those with
matted adhesions). However, to our best knowledge, our
study is the first to show that patients treated with surgery
for SBO had 60 % less frequent subsequent SBO symp-
toms at home compared to patients with conservative
treatment.
The benefit of surgical treatment observed in our study
has to be balanced with the risks associated with surgery,
particularly for patients with comorbidities and advanced
age. Moreover, laparoscopic adhesiolysis for chronic
abdominal pain seems not to be effective [21]. Thus, an
individualized treatment should be considered, based on
the severity of the SBO episode as well as the general
medical condition of the patient. A prospective study
combining a score of severity of SBO [16] and a score
indicating patient medical condition (APACHE II score
[22] ) could help in the decision for taking either a con-
servative or a surgical approach.
Table 3 Recurrence of SBO symptoms, univariate logistic regression
Variable Surgical
management (n = 69)
Conservative
management (n = 61)
OR (95 % CI) p value
Recurrence of SBO symptoms (any) (%) 24 (34.8) 35 (57.4) 0.4 (0.2–0.8) 0.011
Abdominal pain (%) 23 (33.3) 34 (55.7) 0.4 (0.2–0.8) 0.011
Nausea and vomiting (%) 7 (10.1) 8 (13.1) 0.7 (0.3–2.2) 0.598
Odds ratios (OR) and p values were calculated using univariate logistic regression analysis
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Although it is commonly accepted that early operation
for SBO (\24 h) decreases immediate morbidity [20, 23],
no difference in the long-term outcomes between patients
operated within or after 24 h of admission were found in
our study. Based on this observation, it seems reasonable to
attempt conservative management for patients without any
signs of severity. Surgical treatment would be recom-
mended in the absence of bowel function recovery within
24 h after an oral water-soluble contrast agent test [24].
A limitation of the present study is the selection bias
regarding assignment of patients to study groups. Patients
in the conservative group had lower severity scores.
However, it seems unlikely that this bias affects the long-
term outcomes. Moreover, the patient groups were similar
regarding major causes for SBO, i.e., colectomy, hyster-
ectomy, and appendectomy, as compared to historical
series [7]. A randomized controlled trial would be infor-
mative to definitively determine whether surgery is actually
advantageous in terms of recurrence of SBO in non-
strangulated SBO patients. However, such a study would
expose patients with no signs of severity to the risks of a
surgical operation and is ethically questionable. Moreover,
a certain amount of bias in a randomized study comparing
conservative and surgical management seems unavoidable.
Another fact that would limit the feasibility of such a study
is the inability to determine with confidence whether the
small bowel is strangulated or not, which would restrict the
investigators from obtaining a homogeneous group with
non-strangulated SBO only.
In conclusion, this study indicates that patients under-
going surgical management for SBO had reduced risks of
recurrence requiring hospitalization, as well as SBO
symptoms as compared to those with conservative treat-
ment. Based on these findings, the following clinical rec-
ommendation for the management of small bowel
obstruction may be considered: patients with three or more
of the following criteria (pain duration C4 days, abdominal
guarding, leukocyte C10 9 109/l, C-reactive protein
C75 mg/l, free fluid C500 ml on CT scan, or reduced
contrast enhancement on CT scan) should undergo prompt
surgical intervention as it allows both obstruction removal
and long-term reduction of recurrent SBO episodes. The
decision to operate should also take into account the evo-
lution of the clinical status and laboratory values, addi-
tional CT findings (e.g., volvulus, transition zone, reduced
contrast enhancement, small bowel feces sign), as well as
the patient’s general condition, comorbidities, and surgical
history.
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